Keyword Analysis & Research: ertapenem vs meropenem
Keyword Research: People who searched ertapenem vs meropenem also searched
Search Results related to ertapenem vs meropenem on Search Engine
-
JMM Profile: Carbapenems: a broad-spectrum antibiotic - PMC
https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC8744278/
WEBDec 10, 2021 · Ertapenem can be used prophylactically for patients undergoing invasive surgery. Meropenem can be used to treat meningitis due to its ability to penetrate meninges. Compared to imipenem and meropenem, ertapenem has a longer half-life and slightly narrow spectrum of use and is ineffective against P. aeruginosa .
DA: 18 PA: 87 MOZ Rank: 31
-
Comparative review of the carbapenems - PubMed
https://pubmed.ncbi.nlm.nih.gov:443/17488146/
WEBThe current role for imipenem/cilastatin and meropenem in therapy remains for use in moderate to severe nosocomial and polymicrobial infections. The unique antimicrobial spectrum and pharmacokinetic properties of ertapenem make it more suited to treatment of community-acquired infections and outpatient intravenous antimicrobial therapy than for ...
DA: 50 PA: 57 MOZ Rank: 90
-
Antibiotics - EMCrit Project
https://emcrit.org:443/ibcc/antibiotics/
WEBMar 19, 2024 · choice of ertapenem vs. meropenem Meropenem: May have better tissue penetration (e.g., with a stronger track record in the treatment of meningitis). Ertapenem: ⚠️ Hypoalbuminemia (<2.5 g/dL) may reduce the half-life of ertapenem, correlating with an increased risk of mortality.
DA: 88 PA: 65 MOZ Rank: 32
-
Ertapenem vs Meropenem Comparison - Drugs.com
https://www.drugs.com:443/compare/ertapenem-vs-meropenem
WEBCompare Ertapenem vs Meropenem head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
DA: 65 PA: 35 MOZ Rank: 68
-
The Clinical Efficacy and Safety of Ertapenem for the Treatment of
https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC4461781/
WEBMay 27, 2015 · Ertapenem may be preferred over imipenem or meropenem because of its lower cost, feasibility for outpatient intramuscular therapy, and potential value for reducing carbapenem resistance in Acinetobacter baumannii (A. baumannii) and Pseudomonas aeruginosa (P. aeruginosa). In addition, there is also scarcity of reports concerning the …
DA: 24 PA: 98 MOZ Rank: 44
-
Carbapenem stewardship with ertapenem and antimicrobial …
https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC7670755/
WEBNov 6, 2020 · However, some authors advocate ertapenem as a strategy to reduce resistance to meropenem and imipenem.
DA: 97 PA: 22 MOZ Rank: 8
-
Ertapenem Versus Meropenem for the Treatment of Extended …
https://journals.sagepub.com:443/doi/abs/10.1177/10600280231205219
WEBOct 26, 2023 · Patients were matched on age, sex, lowest albumin, and in a 1:2 ratio of ertapenem to meropenem. The primary outcome, clinical failure, was a composite of 30-day mortality, antibiotic escalation, and microbiological failure.
DA: 46 PA: 95 MOZ Rank: 8
-
Carbapenems - Infectious Diseases - Merck Manual Professional …
https://www.merckmanuals.com:443/professional/infectious-diseases/bacteria-and-antibacterial-drugs/carbapenems
WEBReviewed/Revised May 2022. View Patient Education. Carbapenems include. Imipenem. Carbapenems are parenteral bactericidal beta-lactam antibiotics that have an extremely broad spectrum. They are active against. Haemophilus influenzae. Anaerobes.
DA: 6 PA: 43 MOZ Rank: 73
-
Clinical efficacy of ertapenem vs. other carbapenems for the …
https://www.sciencedirect.com:443/science/article/pii/S2213716523000486
WEBJun 1, 2023 · Both ertapenem and other carbapenems, including imipenem, meropenem, and doripenem, are recommended in the treatment of extended-spectrum-β-lactamase (ESBL)-producing Enterobacterales infection. However, whether ertapenem is as effective as other carbapenems for ESBL-producing Enterobacterales remains unclear.
DA: 56 PA: 44 MOZ Rank: 5
-
Ertapenem, the first of a new group of carbapenems
https://academic.oup.com:443/jac/article/52/4/538/713744
WEBOct 1, 2003 · Ertapenem is sufficiently different in some key attributes from imipenem and meropenem that we can no longer consider all available carbapenems as if they were a homogeneous class.
DA: 82 PA: 81 MOZ Rank: 35
